Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Thinq Pharma CRO Limited
Eligibility
Inclusion criteria
Inclusion criteria: We will consider the following criteria for retrospective analysis. 1. Male or Female subjects of age 18 to 75 years (both inclusive). 2. Subjects diagnosed with COVID-19 by RT-PCR. 3. Patients provided oral & nasal swabs for test 4. Females of child-bearing potential (i.e., who were not chemically or surgically sterilized or who were not post-menopause) must have had a negative urine pregnancy test. 5. Females of child-bearing potential who have used a medically accepted method of contraception that was considered reliable in the judgment of the investigator. 6. Subjects who have taken Thinqure 20 as prescribed by Investigator.
Exclusion criteria
Exclusion criteria: Subjects were excluded on the following basis: 1. Patients with a history of intracranial bleeding 2. Patients without a completed medical history 3. Patients, who were suffering from any haemoglobinopathies such as thalassemia that could interfere with oxygen carriage in the blood. 4. Patients, who were smokers or consumed alcohol. 5. Patients, who were suffering from active malignancy along with squamous cell or basal cell skin cancer. 6. Female subjects who were pregnant or lactating or planning to become pregnant during the study period. 7. Females who were not ready to use acceptable contraceptive methods during the course of study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in viral load from baseline to end of study visit.Timepoint: Day 1 to Day 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| The assessment of safety and tolerability of Investigational Product.Timepoint: Day 1 to Day 5 | — |
Countries
India
Contacts
Public ContactDr Milind Gharpure
Mediclin Clinical Research
Outcome results
None listed